• TransCanna recently acquired a 196,000 sq. ft cannabis-concentrated hub in Stanislaus County, California, in keeping with its expansion plans to develop a global cannabis marketplace
• It also received gross aggregate proceeds of more than C$10 million in private placement funding, which is being used for equipment purchase, acquisitions and other business activities
• The company has hired a new general manager, Alan R. Applonie, who has decades of infrastructure experience working with Amazon, Starbucks, Walmart, 7-Eleven and Kroger
• TransCanna is aiming to buy and develop 15 premium cannabis brands in California

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) is a Canadian company engaged in developing, integrating, scaling and channelizing cannabis- and hemp-related marketing activities in a closed-loop ecosystem. The company currently owns arguably the largest expanse of vertically integrated cannabis concentrated workplace in California.

Recently, TransCanna successfully closed its second round of private placement funding since its IPO on January 9, 2019, which fetched the company gross aggregate proceeds of C$10 million (http://ibn.fm/lSs7Z). The proceeds of this funding are being used by the company in acquiring equipment and developing its existing 196,000 sq. ft cannabis unit in Modesto, Stanislaus County, California. The proceeds will also be used for additional acquisitions, and for further strengthening its company resources.

In addition, TransCanna has appointed Alan R. Applonie as the general manager of its Modesto facility (http://ibn.fm/ndEOZ). The appointment was made after screening of top-tier talent from the industry for a period of six months. Applonie most recently oversaw a major consumer goods facility that generated approximately $300 million in annual gross revenues. He will be overseeing all of the manufacturing and related activities at the 196,000 sq. ft hub, as well as other units being acquired in Stanislaus County.

With this one single move, TransCanna has instilled years of experience, knowledge and expertise into the management of the company. Applonie’s forte lies in managing supply-chain operations and processes related to agricultural-based CPG products. He has also been associated with consumer goods giants like Amazon, 7-Eleven, Kroger, Walmart and Starbucks.

The need for a seasoned organization that effectively synchronizes all cannabis-related business activities is at its peak right now. TransCanna aspires to build 15 top-notch cannabis brands that will enter the retail marketplace in the next two years. The company has non-binding LOIs with four separate brands and is performing due diligence on each company. From hemp-based coconut oil to cannabis-infused fruits snacks, TransCanna is making its foray into the mainstream marketplace and looking to become the largest revenue-generating publicly traded company in California cannabis.

The company recently released a video tour of its facility, which provides more information about the vertically integrated cannabis industry (http://ibn.fm/8CidF).

For more information, visit the company’s website at www.TransCanna.com

NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://ibn.fm/TCAN

• Supreme Heights will focus on opportunities in the UK and European CBD health and wellness space
• The investment platform will benefit from Supreme Cannabis’ vast industry experience and connected leadership team
• Supreme Cannabis’ CEO expects the move to enhance revenue value for investors

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a leading Canadian cannabis producer, recently announced its launch of Supreme Heights, a new investment platform. Supreme Heights, established in London, will take advantage of opportunities within the United Kingdom and Europe’s CBD health and wellness sector.

While Supreme Heights has been initiated as a separate entity, the platform has solid foundational support and will benefit from Supreme Cannabis’ regulatory, product commercialization, supply chain, marketing and capital markets expertise, as well as corporate support services (http://ibn.fm/Fsts5). Additionally, Supreme Heights will benefit from Supreme Cannabis’ experience launching premium brands and its team’s history of supporting health and wellness companies in Canada and abroad.

Supreme Cannabis CEO Navdeep Dhaliwal described the investment in Supreme Heights as a way to increase value for existing Supreme Cannabis shareholders. “The rapidly evolving CBD markets in the UK and Europe present compelling investment opportunities given the promising environments for new health and wellness companies to establish differentiated brands and capture meaningful market share,” Dhaliwal noted in a news release. “Supreme Heights is positioned to quickly act on attractive opportunities and establish an early mover advantage in the space.”

Supreme Heights CEO Patrick Morton brings a diverse and valuable track record to the new position. He has more than a decade of capital markets experience and significant industry relationships. As a co-founder of Cannabis Invest UK, the United Kingdom’s leading cannabis investor conference, Morton has witnessed the evolving cannabis industry change and develop, and he has spent the last three years building a network of local and global cannabis and CBD companies. He has also played an integral role in discussions and action surrounding global cannabis investment opportunities.

In describing Supreme Cannabis’ role in the launch of Supreme Heights in a news release, Morton said, “We have gained a valuable strategic partner with a top-tier management team and highly developed corporate services. With guidance from Supreme Cannabis, we intend to make target investments in wellness brands that provide exposure to value-add categories in the UK and Europe’s CBD market, including vaporizers, edibles and beverages, topicals, and ancillary services… We are committed to positively contributing to this emerging industry and intend to support companies that share our standards for quality, sustainability and innovation.”

Supreme Cannabis has become one of Canada’s premium cannabis producers as a result of its multipronged approach. The company has sincere respect for its informed and discerning customers, recognizing their need for a premium brand delivering a quality product. This high regard for customers, paired with Supreme Canada’s premium product quality and ability to distribute products coast-to-coast across Canada, has enabled the company to wholesale for up to one-third higher in price than other competing brands in the Canadian cannabis market.

The company’s reputation for quality and ease of access to premium products has left Supreme Cannabis well positioned to take advantage of the growing demand for cannabis in Canada. The country’s total cannabis market, which includes both medical and recreational cannabis products, is expected to yield up to $7.17 billion in 2019 total sales (http://ibn.fm/nRJWU). Additionally, the Canadian Imperial Bank of Commerce predicts that the cannabis industry will value at $6.8 billion by 2020, which is larger than the country’s hard liquor market and almost as large as its wine market.

For more information, visit the company’s website at www.Supreme.ca

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF

• Grapefruit is a premier manufacturer and distributor in California’s legal cannabis marketplace
• The company completed a reverse acquisition of Imaging3
• Grapefruit recently launched a new product line, Sugar Stoned

Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) is a premier cannabis manufacturer and distributor in the California legal cannabis marketplace with its own branded product lines. It offers professional assistance to other cannabis companies in branding, compliant packaging, extraction services, edible manufacturing services and distribution logistics. The company created a fully compliant strategy to bring unlicensed brands into the legal marketplace. Grapefruit is a seed-to-sale, vertically integrated company sourcing active ingredients and creating branding, packaging and manufacturing. The company provides wholesale and licensed cannabis distribution to ensure that the brands it works with get into dispensaries.

In January 2018, Grapefruit acquired its California cannabis licenses and subsequently began distribution of cannabis products. Grapefruit’s cannabis- and CBD-extraction laboratory and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California.

‘IGNG’ was originally the public trading ticker for Imaging3, a diagnostics technology company that is now continuing services as a private company. In June, Grapefruit announced that, upon approval of IGNG’s board of directors, it successfully completed the reverse acquisition of Imaging3 (http://ibn.fm/BDJkQ).

In a news release, former Imaging3 CEO John Hollister commented, “Grapefruit is poised for a great future.” Hollister went on to say that, given the potential of the expanding cannabis market and the company’s strong cannabis-market potential, shareholders are now in a position to see a larger value appreciation with lower risk.

Grapefruit has big plans for the future that include the expansion of current extraction laboratory operations to increase efficiencies and output, as well as the expansion of distribution services throughout California and pursuit of additional cannabis licenses for permitted cannabis manufacturing and cultivation. “In this quarter alone, Grapefruit will be launching its new line of unique infused cannabis edible and CBD products,” added Grapefruit CEO Bradley J. Yourist.

In addition, on June 21, 2019, the company announced that it will start retail sales of its first brand of cannabis-infused edible gummies in California under the trade name ‘Sugar Stoned’ (http://ibn.fm/rerYF). Grapefruit’s corporate vision is to become a seed-to-sale, fully vertically integrated ethical and compliant cannabis and CBD (cannabidiol) product company. The new Sugar Stoned signature gummies are available in eight flavors: blue raspberry, cherry, grape, peach, pineapple, sour apple, strawberry and watermelon. These flavors were chosen following consultation with cannabis retailers across California.

Sugar Stoned consumers know that they are receiving the highest quality product. All of Sugar Stoned’s infused gummies are tested and certified by a third-party lab to be pesticide and heavy-metal free. In Q3 2019, Grapefruit is preparing to introduce several unique infused offerings, as well as launching a new line of THC- and CBD-vaporizer cartridges.

For more information, visit the company’s website at www.GrapefruitBlvd.com

• PBIO’s proprietary Ultra Shear Technology (UST) platform achieves the long sought-after ability to create truly water-soluble CBD oil that can provide optimized solubility and bioavailability for CBD absorption
• As a result of the long sought-after demand for safe and effective water-soluble CBD, the company believes that a doubling in its annual revenue run-rate over the next year is very possible, based on the sale of this totally new, proprietary instrument system; market impact includes CBD products, nutraceuticals, foods and beverages, cosmetics and other oil-based markets
• Independent, university-affiliated analytical lab test results prove that PBIO’s UST platform creates high quality, visually clear nanoemulsion mixtures of CBD oil and water and that the CBD molecule is preserved throughout the process
• The overall cannabinoid market is expected to reach $22 billion by 2022, with CBD oil-based supplements serving as a cornerstone of the booming consumer trend

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables and related services for the global life sciences and other industries, has just announced that its proprietary Ultra Shear Technology (UST) platform has been optimized for the unique purpose of creating high quality nanoemulsions of CBD oil in water. Independent test results have shown that these CBD oil nanoemulsions retain nearly 100 percent of the CBD molecule after processing, without altering the molecule or generating impurities. Given this new highly-effective, non-chemical ability to make truly water-soluble CBD – a solution that meets a huge long-standing need – the company announced today a major focus on the cannabis/CBD market (http://ibn.fm/RWh9W).

UST is a novel process that has potential in a wide range of commercial applications, including extending the shelf life of some food products and making two or more insoluble liquids (like oil and water) soluble. UST is based on the use of intense shear forces generated from ultra-high-pressure valve discharge (http://ibn.fm/1F6iN). PBIO’s UST process has most recently been independently verified by chemists at NutraFuels, Inc. (OTCQB: NTFU), which has a U.S. Food and Drug Administration (“FDA”) inspected, highly qualified analytical testing laboratory with state-of-the-art equipment.

“Using a powerful laboratory method called HPLC to measure the concentrations of CBD and potential impurities, we determined that no appreciable amount of CBD was lost during the UST process,” Cooper Dodd, R&D Scientist at NTFU, stated in a news release (http://ibn.fm/g2Fd6). “These results compare well to our standard processing method of ultrasonication, which can carry a risk of measurable loss of CBD, and sometimes creates the appearance of impurities if not performed properly. While there is more work to be done, as a nutraceutical manufacturer with products already on the market, we see these results as a robust leap towards better optimization of our CBD-enhanced products.”

PBIO has released two short videos (http://ibn.fm/PosOT and http://ibn.fm/DH9n7) showing how its patented UST platform was able to process CBD plant oil into a water-soluble nanoemulsion. When the UST-processed CBD oil was added to different liquids – such as a soft drink, a sports drink and a beer – the nanoemulsified CBD oil completely dissolved in each liquid.

For many oil-based products, the ability to create nanoemulsions can improve the products’ absorption, medicinal benefits, visual appearance and sensory presentation, Dr. Bradford A. Young, chief commercial officer of Pressure BioSciences, stated in a news release introducing the videos (http://ibn.fm/d7tJF).

“The potential for the UST platform to impact the CBD industry is promising, with the total cannabinoid market expected to hit $22 billion by 2022 with CBD oil-based supplements being the cornerstone of this market,” Young said (http://ibn.fm/1nUlU). “More importantly, while CBD is an attractive opportunity for our proprietary UST platform, we believe that the nutraceuticals, topicals and cosmetics, and food and beverage markets as mentioned could be 10-50 times larger. We will be addressing these additional market opportunities in parallel with our efforts in CBD.”

Cannabidiol (CBD), is a naturally occurring compound found in cannabis and hemp plants that is non-psychoactive. CBD can now be found in a dizzying variety of CBD-infused products, including edibles, lotions, capsules, medications and other health and wellness products, as The New York Times reported in an article reviewing CBD’s history and future potential (http://ibn.fm/bt6pd).

Dr. Keith Warriner, professor of food science at the University of Guelph (Toronto), and a recognized expert in the cannabis industry, said that PBIO’s UST platform is a significant achievement.

“The data released today on UST-generated nanoemulsions of CBD oil are very impressive. Creating nanoemulsions of CBD oil with full preservation of CBD throughout the process, while not generating impurities, remains a significant challenge in the industry. These data indicate that UST can achieve that goal, thereby offering great promise to the future,” Warriner stated in February.

PBIO believes that its proprietary Ultra Shear Technology can help a diverse variety of customers to develop a vast array of new and beneficial products spanning multiple large markets including CBD and nutraceuticals, cosmetics and topicals, food and beverages, drug delivery and more, Young concluded.

For more information, visit the company’s website at www.PressureBioSciences.com

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

• The Green Organic Dutchman’s focus is on being the market’s foremost global organic cannabis brand
• The company recently launched a worldwide strategic hemp division
• TGOD aims to provide a suite of premium consumer-preferred products

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is a premium cannabis company that grows high-quality, organic cannabis with sustainable, all-natural principles. Established in 2012, TGOD focuses on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, along with the Canadian adult-use market. TGOD’s senior management team has wide-ranging experience in executive and operational activities specific to CPG (consumer packaged goods), consumer products, and the cannabis and finance industries.

TGOD’s products are laboratory tested to ensure that patients have access to a standardized, safe and consistent product. Headquartered in Mississauga, Ontario, TGOD has a planned capacity of 219,000 kg and is building 1,643,600 square feet of cultivation and processing facilities across the Canadian provinces of Ontario and Quebec, as well as in Jamaica and Denmark.

Recently, TGOD launched a global strategic hemp division, through which it plans to expand into the worldwide organic hemp market in a significant way. The company previously entered the flourishing European hemp market via joint ventures, along with its 2018 acquisition of HemPoland, a company with extensive experience in the European CBD (cannabidiol) market (http://ibn.fm/ilTR2). TGOD itself has considerable experience from which to significantly ramp up expansion plans. The company’s global strategic hemp division will work to expand into territories in Canada, Jamaica, Poland, Mexico and the United States. TGOD’s stock rose after the announcement of the company’s new division.

HemPoland has vast experience in cultivating and processing EU-registered hemp varieties that are similar to those now allowed for cultivation in Canada. HemPoland’s revenue for Q1 increased by almost 30 percent quarter over quarter as demand for high-quality hemp CBD products in Europe gained momentum (http://ibn.fm/7uVeD). TGOD’s global strategic hemp division will be tasked with providing genetics, training on organic methods and standard operating procedures, and regulatory insights and other advisory support to the company’s global partners.

“With the global CBD market expected to hit $22 billion in less than three years, it is clear that the segment is drawing substantial consumer demand,” TGOD CEO Brian Athaide stated in a news release. “Our team has years of direct hands-on experience in the CBD space, and we are excited to use this advantage to execute on a fast-moving market expansion strategy. CBD is a wellness product and has a natural fit with TGOD’s certified organic positioning and the large segment of consumers who are increasingly demanding natural and organic products.”

In addition, TGOD has partnered with Eaton Corp., a global power-management company that is providing research and optimization. This partnership will allow TGOD to have some of the lowest electricity input costs in the business. TGOD also has a partnership with Canada’s second-largest construction management company, Ledcor.

TGOD has a facility in Ancaster, Ontario, with a funded expansion of 166,000 square feet capable of producing 17,500 kg of high-quality organic cannabis annually. Plans also include a 20,000-square-foot enclosed facility, which will add 2,000 kg of capacity to the company’s projected output. In addition, TGOD has more than 1.4 million square feet planned internationally (http://ibn.fm/TdzJj). Furthermore, the expectation is that the company’s strategic beverage division will be an organic R&D center for novel and proprietary cannabinoid-infused beverages, advanced products, advanced-product development and pilot manufacturing.

Growing to scale with logistical and infrastructure controls, TGOD represents a compelling investment opportunity for investors wanting a position in the premium organic cannabis market. The company continues to focus on creating novel and proprietary strains and differentiated products. TGOD is actively pursuing its mission to provide organic cannabis solutions to enhance people’s lives.

For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

• Earth Science Tech is a Florida-based company with a vision of enhancing the quality of people’s lives through varied wellness initiatives as part of a growing $4.2 trillion industry
• The company’s two subsidiaries have a targeted focus on helping women who might not normally pursue health care to assess and treat STIs, as well as on utilizing hemp derivatives as therapy for a variety of maladies
• ETST also supports a favored entity’s efforts to gain non-profit status for accepting grants that would further CBD studies and assist the company in donating its products on the basis of need

The health and wellness industry continues to accelerate annual sales of products and philosophies designed to help people live life and love it, propelled in large part by concerns about the rising costs of health care and the decrease in age of patients reporting select chronic ailments, including heart disease. The Global Wellness Institute reports that wellness industry revenues increased by 6.4 percent annually from 2015-17 to become a $4.2 trillion market that is growing nearly twice as fast as the global economy (http://ibn.fm/afG7j).

Florida-based biotech company Earth Science Tech Inc. (OTCQB: ETST) has built a variety of partnerships that support its two wholly owned subsidiaries, as well as a favored non-profit entity, in their endeavors to advance consumers’ wellbeing. The company’s mission is focused on cannabis/industrial hemp and medical devices.

Subsidiary Earth Science Pharmaceutical is committed to bringing low-cost, non-invasive testing processes and vaccines for sexually transmitted infections to market to help women improve the quality of their lives. The company’s first medical device, Hygee, is a home kit designed as a modified panty liner to allow for the self-collection of a gynecological specimen that can be tested for two types of infections – chlamydia and gonorrhea. It gives women the ability to self-collect specimens in a non-clinical setting before sending them to a laboratory that will process the specimens and notify them if they test positive so that they can seek treatment.

The motivation behind the technology is to help women and girls in high-risk situations, who might not be willing or able to seek out assistance through traditional medical care facilities, take responsible action for their own wellbeing with the help of online ordering and home screening.

ETST’s second subsidiary, Cannabis Therapeutics, is investing in the medicinal power of hemp-derived cannabidiol (CBD). Earth Science Tech holds three provisional application patents for a CBD product that the company aims to use in developing treatments for breast and ovarian cancers, and for two generic pharmaceutical drugs with a CBD foundation.

Industrial hemp-based CBD and full-spectrum oils provide the company a core operation with increasing revenues, but Earth Science Tech has also been invested in research and developmental lab work that it hopes to continue for advancing varied high-quality natural hemp extracts and identifying their distinct properties. In addition to breast and ovarian cancer treatments, the company aims to further non-prescription therapies for chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea and general aging-related maladies.

ETST’s formulations are expected to include options such as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs and may include products such as CBD as a natural constituent of hemp oil, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products (http://ibn.fm/5Hokn).

As a companion entity to Earth Science Tech’s subsidiary operations, the company backs favored entity Earth Science Foundation’s effort to become a non-profit organization that can accept grants and donations to conduct further studies and assist in donating Earth Science Tech’s effective CBD products to those in need.

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

• Legislative changes and growing demand are forecast to enable the industrial hemp sector to grow at a CAGR of 13.7 percent through 2026
• The worldwide market is expected to eclipse $13 billion within the next seven years
• Such rapid growth is expected to provide strategic expansion opportunities for innovative cultivation equipment suppliers like Sugarmade Inc.

Sugarmade Inc. (OTCQB: SGMD), a major supplier to the booming hydroponic cultivation sector, looks set to benefit from the many opportunities presented by the quickly expanding industrial hemp sector, as statistics indicate that the market is anticipated to reach $13.03 billion by 2026 from $4.63 billion in 2018, expanding at a CAGR of 13.7 percent (http://ibn.fm/fYbkb).

There are several reasons why this market is forecast to expand at such a rapid rate. Hemp is a highly versatile plant that can be cultivated as a renewable source for raw materials utilized by various industries. In addition, hemp is a very lucrative rotation crop due to its ability to detoxify the soil and take in carbon dioxide.

Several subdivisions of the industrial hemp sector are anticipated to grow at a much higher rate than the average. The hemp seed segment, in particular, is expected to grow at a CAGR of 17.1 percent through 2025 – an increase in demand attributed to mounting interest in products like hemp oil and nutraceuticals (http://ibn.fm/b9nyS). Hemp seeds feature approximately 35 percent oil, which is a much-needed resource for the production of various popular products.

The textile industry is also promoting growth, since hemp fiber can be used in the manufacture of fabrics, apparel, fine textiles and accessories. Additionally, the personal care industry is contributing to propelling industrial hemp, with body care products based on hemp growing in prominence as more and more people begin to understand the potential benefits that this resource brings to the table.

Animal care, food and beverages, paper, automotive and other industries come next in the list of sectors promoting the growth of industrial hemp.

All of this growing demand is expected to provide hemp cultivation equipment suppliers with significant strategic business opportunities.

As a major hydroponics cultivation sector supplier that also provides equipment to the hemp industry, Sugarmade expects to tap into these new opportunities to cement its position and continue growing its operations. In April 2019, the company entered into an agreement with Hempistry Inc. to deliver resources for plant micropropagation. The contract is anticipated to remain ongoing as Hempistry expands its operations domestically and internationally.

Legislative changes like the passing of the federal Farm Bill at the end of 2018 have enabled companies like Sugarmade to gain traction in the industrial hemp sector. In Kentucky alone, at least 42,000 acres of hemp will be planted in the near future, Sugarmade CEO Jimmy Chan said in a news release. When all of the other hemp cultivation states are also taken into consideration, it becomes easy to see how demand for quality equipment could multiply rapidly.

Forecasts for 2019 suggest that hydroponics and hemp cultivation are two of the top five agricultural investment trends. Hydroponics techniques can be adapted to many different crop varieties, allowing for more control over the growing environment and higher yields.

For more information, visit the company’s website at www.Sugarmade.com

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

• CIIX anticipates growth in the Asian region via merger and acquisition activities
• The company’s CEO expects sales to double over the next 12 months
• CIIX’s core business for years has been focused on educational services and delivering financial and investment news in real-time

ChineseInvestors.com Inc. (OTCQB: CIIX) CEO Warren Wang said, in a Redchip Money Report interview with host Dave Gentry, that investors should know that CIIX is seeking to expand its future business via merger and acquisition activities in the Asian region (http://ibn.fm/SVdPq).

During the interview, Wang projected CIIX’s sales to double over the next 12 months. Wang noted that the company has long been reaching a Chinese-speaking audience in the United States and Canada with investment information on issues ranging from cryptocurrency to CBD.

“We are going to do some merger/acquisition to expand our business in the Asian region,” Wang said in the interview. CIIX is a multifaceted company, driven not only by educational services but also by sales of cosmetics, hemp wine and CBD. At retail, CIIX operates a pop-up store in California at the Glendale Galleria Mall.

CIIX maintains a website, ChineseFN.com, that has a following of more than 100,000 registered users and 5,000 subscribers, according to Wang. The site offers its audience up-to-date analysis on currencies and other financial information.

Wang explained that there are more than four million Chinese Americans and Chinese Canadians in North America, and CIIX plans to expend additional advertising dollars to grow its retail businesses, both online and in-person.

CIIX is a diversified company that offers its audience of Chinese-speaking investors real-time market commentary, analysis and education-related services in Chinese character language sets.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

• Wildflower’s sales growth is directly related to its strategic partnerships and the launch of new products
• The company’s CBD-infused products are now available at wellness guru Joel Warren’s ‘The Salon Project’ at Saks Fifth Avenue as part of a continued product offering expansion that began in March 2019
• Wildflower is expected to continue working on new CBD and hemp-derived products in order to solidify its leading market position

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF), a Vancouver-based company with an emphasis on plant-based health and wellness products, reported a 78 percent increase in sales for its fiscal quarter ended March 31, 2019, reaching $2.5 million, according to an official company announcement (http://ibn.fm/CAjsA). The growth on a quarterly basis has been an ongoing trend since Wildflower initiated sales of its popular line of hemp CBD products.

Wildflower also announced financial results for City Cannabis Corp. – an entity that Wildflower aims to acquire in the coming weeks. City Cannabis had revenue of $1.8 million for the quarter ended March 31, 2019. The opening of the company’s two stores in January contributed to these favorable financial results. Upon its finalization, the City Cannabis acquisition is expected to be accretive to Wildflower’s earnings.

Apart from announcing its financial results, Wildflower has also released statements about strategic steps undertaken in line with the company’s expansion efforts.

On May 30, 2019, Wildflower announced the launch of the company’s CBD infused products at wellness guru Joel Warren’s ‘The Salon Project’ (http://ibn.fm/OXuIZ). The collaboration will give clients benefiting from the Saks Fifth Avenue salon services an opportunity to experience Wildflower products in a curated shop-in-shop CBD beauty corner.

Celebrity beauty and wellness icon Joel Warren has been a leader in the hair care industry for more than 30 years. His salon focuses on the delivery of a signature experience that brings together the know-how of stylists with the best beauty and wellness products.

This isn’t the first partnership announced by Wildflower in 2019. At the beginning of the year, the company initiated a strategic New York expansion which saw its products become available in more than 20 health and wellness stores throughout Manhattan (http://ibn.fm/r4dBV). New York became a city of focus due to its ability to set global trends. The move quickly paid off, as more than 40 percent of Wildflower’s online sales now come from the New York area.

Over time, Wildflower has been working to expand its product offerings – a strategic initiative that has enabled collaborations like the one with Warren.

In March 2019, the company announced that it was expanding its offerings through the introduction of Pure and Pure Plus tinctures. Both feature hemp-derived CBD, hemp seed oil and milk thistle. The tinctures provide relief from inflammation and support for healthy liver and heart function.

Wildflower announced that it will continue working on new releases as a part of the company’s ongoing product development efforts. The company has also announced plans to expand into Europe’s CBD market via an agreement with Poland-based wellness distribution company Two Towers and an extension of the Omega Rex pharmaceutical chain in the Warsaw area.

“Consumers are drawn to Wildflower because of the effectiveness and range of options available in our product lineup. The strong brand loyalty of Wildflower customers reflects the time and resources invested in our pipeline of products,” CEO William MacLean said in a news release (http://ibn.fm/Kzw6Q).

For more information, visit the company’s website at www.WildflowerBrands.co

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at http://ibn.fm/WLDFF

• Plus Products’ brands have seized five spots in a top-10 lineup of California cannabis offerings, including the leading position
• The company plans to expand its product line after recently completing a C$20 million capital raise
• Plus Products has secured an option to purchase Emerald Bay Wellness LLC, a California-based cannabis oil manufacturer

What does it mean when a company has five of the top 10 edible SKUs in the largest cannabis market in the world? It could mean that, like Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), it’s on its way to market control. Plus Products, based in San Mateo, California, has emerged as “the dominant manufacturer of edibles in California, which is no small feat,” according to Chris Parry, a marijuana marketing consultant for Yahoo Finance (http://ibn.fm/2u9fI). It’s no surprise, then, that Plus Products has been ranked as the top cannabis edibles brand in California (http://ibn.fm/F4H9d), and its financials have started to reflect that lofty status. Revenues for Q1 2019 were $3.24 million, marking a 272 percent increase year-over-year.

Plus Products has found a way into the hearts of residents in the Golden State, no doubt because its hugely popular cannabis-infused gummies and mints have found favor with their palates. The latest rankings compiled by data intelligence analyst Headset from retail sales data show the company’s products placing in the tenth, ninth, sixth, second and first positions in the gummy steeplechase (http://ibn.fm/zyDh0). Refresh – Pink Lemonade Gummies (30mg CBD, 70mg THC) was in tenth place; CBD/THC 9:1 Mango Gummies (90mg CBD,10mg THC) was in ninth; Create – Hybrid Sour Blueberry Gummies 20-Pack (100mg) took sixth place; Restore – Indica Blackberry Lemon Gummies 20-Pack (10mg CBD, 90mg THC) was in second; and Sour Watermelon Gummies 20-Pack (100mg) took the top spot. Of the other five places in the top 10, three went to one competitor and two to another.

Since its introduction in 2015, the PLUS brand has climbed to the top of the pack. Its performance reflects a focused strategy. Rather than being all things to all men, Plus Products has gone straight for the palate. PLUS operates through a wholly owned subsidiary, Carberry, and currently has five cannabis-infused gummy candy SKUs (in addition to limited edition SKUs) that are sold in over 200 licensed dispensaries and delivery services. All products under the PLUS brand are produced in the company’s 12,000-square-foot, food-safe cannabis manufacturing facility in Adelanto, California.

Plus Products came to market in October 2018. In an IPO on the Canadian Securities Exchange (CSE), the company offered 6,153,847 subordinate voting shares at a price of C$3.25 per share for total gross proceeds of C$20 million. The company’s shares have since been trading on the CSE under ticker symbol ‘PLUS’. The company intends to use the proceeds of the capital raise for new product development, to increase manufacturing capacity, to upgrade factory automation and to strengthen working capital.

Earlier in June, Plus Products announced that it had acquired an option to purchase Emerald Bay Wellness LLC, a California-based cannabis oil manufacturer. The option grants PLUS the irrevocable right, but not the obligation, to purchase all of the business assets of Emerald Bay Extracts for cash and stock consideration (http://ibn.fm/cHQUR).

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF